These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 18632214)
1. Effect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancer. Fortin A; Wang CS; Vigneault E Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):255-60. PubMed ID: 18632214 [TBL] [Abstract][Full Text] [Related]
2. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK; Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826 [TBL] [Abstract][Full Text] [Related]
3. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review. Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065 [TBL] [Abstract][Full Text] [Related]
4. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer. Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer. Shen JG; Cheong JH; Hyung WJ; Kim J; Choi SH; Noh SH J Surg Oncol; 2005 Aug; 91(2):126-30. PubMed ID: 16028285 [TBL] [Abstract][Full Text] [Related]
6. Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. Bhide SA; Ahmed M; Rengarajan V; Powell C; Miah A; Newbold K; Nutting CM; Harrington KJ Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):391-8. PubMed ID: 18692326 [TBL] [Abstract][Full Text] [Related]
7. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma. Tanvetyanon T; Choudhury AM Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers. Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615 [TBL] [Abstract][Full Text] [Related]
9. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer. Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033 [TBL] [Abstract][Full Text] [Related]
10. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819 [TBL] [Abstract][Full Text] [Related]
11. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794 [TBL] [Abstract][Full Text] [Related]
12. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck. Fortin A; Caouette R; Wang CS; Vigneault E Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998 [TBL] [Abstract][Full Text] [Related]
13. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy. Hey J; Setz J; Gerlach R; Vordermark D; Gernhardt CR; Kuhnt T Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1475-80. PubMed ID: 19515505 [TBL] [Abstract][Full Text] [Related]
14. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series. Welz H; Pöttgen C; Abu Jawad J; Wierlemann A; Wittig A; Stüben G; Budach V; Lehnerdt G; Jahnke K; Sack H; Stuschke M Oncology; 2009; 76(6):405-12. PubMed ID: 19407473 [TBL] [Abstract][Full Text] [Related]
15. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality. Rusthoven KE; Raben D; Chen C Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):343-50. PubMed ID: 18374508 [TBL] [Abstract][Full Text] [Related]
16. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck. Fortin A; Wang CS; Vigneault E Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1062-9. PubMed ID: 19036528 [TBL] [Abstract][Full Text] [Related]
17. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer. Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263 [TBL] [Abstract][Full Text] [Related]
18. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Dubray B; Mosseri V; Brunin F; Jaulerry C; Poncet P; Rodriguez J; Brugère J; Point D; Giraud P; Cosset JM Radiology; 1996 Nov; 201(2):553-8. PubMed ID: 8888257 [TBL] [Abstract][Full Text] [Related]
19. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy]. Torbé B Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807 [TBL] [Abstract][Full Text] [Related]
20. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]